MYLAN INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2015-03-02: Form 8-K; Period of report 2015-03-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2015-02-27: Form 8-K; Period of report 2015-02-27; Description 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 8.01 Other Events; Details 1.01.
- 2015-01-30: Form 8-K; Period of report 2015-01-27; Description 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
- 2015-01-29: Form 8-K; Period of report 2015-01-29; Description 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events; Details 5.07.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2015-03-02 | 8-K | 2015-03-02 | 2.02 Results of Operations and Financial Condition | 2.02 On March 2, 2015, Mylan N.V. and Mylan Inc. issued a press release reporting Mylan Inc.’s financial results for the period ended December 31, 2014 and full year 2015 financial guidance for Mylan N.V. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. | d884636d8k.htm |
| 2015-02-27 | 8-K | 2015-02-27 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 2.01 (c) each share of Mylan common stock issued and outstanding immediately prior to the effective time of the Merger was converted into the right to receive one New Mylan ordinary share. 2.03 The information set forth in Item 1.01 of this Current Report is incorporated by reference into this Item 2.03. 3.01 The information set forth in Item 2.01 of this Current Report is incorporated by reference into this Item 3.01. 3.03 At the closing of the Transaction, each issued and outstanding share of Mylan common stock immediately prior to the effective time of the Merger was converted into the right to receive one New Mylan ordinary share. 5.01 The information set forth in Item 2.01 of this Current Report is incorporated by reference into this Item 5.01. 8.01 On February 27, 2015, Mylan issued a press release announcing, among other things, the closing of the Transaction. | d882093d8k.htm |
| 2015-01-30 | 8-K | 2015-01-27 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. 1.02 The disclosure set forth under Item 1.01 above is incorporated by reference into this Item 1.02. 2.03 The disclosure set forth under Item 1.01 above is incorporated by reference into this Item 2.03. | d863032d8k.htm |
| 2015-01-29 | 8-K | 2015-01-29 | 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 5.07 On January 29, 2015, Mylan Inc. (the “Company”) held a special meeting of shareholders (the “Special Meeting”). 8.01 On January 29, 2015, the Company issued a press release announcing shareholder approval of the Business Transfer Agreement. | d859790d8k.htm |
| 2015-01-28 | 8-K | 2015-01-28 | 8.01 Other Events | 8.01 On January 28, 2015, Mylan Inc., a Pennsylvania corporation (“Mylan”), received clearance from the European Commission under the EU Merger Regulation for the pending acquisition (the “Transaction”) of (a) Mylan and (b) Abbott Laboratories’ non-U.S. developed markets specialty and branded generics business (the “Business”) by a new public company organized in the Netherlands (“New Mylan”). | d859374d8k.htm |
| 2015-01-14 | 8-K | 2015-01-13 | 8.01 Other Events | 8.01 On January 13, 2015, members of senior management of Mylan Inc., a Pennsylvania corporation, participated in a presentation and live webcast in connection with the J.P. Morgan 33rd Annual Healthcare Conference. | d841123d8k.htm |